Howard Kaufman

Howard Kaufman

Chief Executive Officer at Ankyra Therapeutics, Inc.

63 year
Health Services
Health Technology
Commercial Services

Profile

Howard Kaufman is currently the President & Chief Executive Officer at Ankyra Therapeutics, Inc. He previously served as the Director-Cancer Center at Rush University Medical Center from 2009 to 2013.
From 2014 to 2017, he was the Chief Surgical Officer at The Cancer Institute of New Jersey.
In addition, he held the position of President at the International Society for Biological Therapy of Cancer from 2014 to 2016.
From 2017 to 2019, he served as the Chief Medical Officer at Replimune Group, Inc. Dr. Kaufman obtained his doctorate degree from Loyola University of Chicago in 1986.

Howard Kaufman active positions

CompaniesPositionStart
Chief Executive Officer 2022-03-21
All active positions of Howard Kaufman

Former positions of Howard Kaufman

CompaniesPositionEnd
REPLIMUNE GROUP, INC. Chief Tech/Sci/R&D Officer 2019-12-30
Corporate Officer/Principal 2016-12-31
President 2015-12-31
Corporate Officer/Principal 2012-12-31
See the detail of Howard Kaufman's experience

Training of Howard Kaufman

Loyola University of Chicago Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Howard Kaufman's experience

Connections

65

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
REPLIMUNE GROUP, INC.

Health Technology

Private companies4

Health Services

Commercial Services

Health Services

Health Services

See company connections
  1. Stock Market
  2. Insiders
  3. Howard Kaufman